A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Neoadjuvant chemoradiotherapy has become the standard treatment for locally advanced rectal cancer. Neoadjuvant chemoradiotherapy not only can reduce tumor size and recurrence, but also increase the tumor resection rate and anus retention rate with very slight side effect. Comparing with preoperative chemotherapy, preoperative chemoradiotherapy can further reduce the local recurrence rate and downstage. Middle and low rectal cancers can benefit more from neoadjuvant chemradiotherapy than high rectal cancer. It needs to refine the selection of appropriate patients and irradiation modes for neoadjuvant chemoradiotherapy. Different therapeutic reactions to neoadjuvant chemoradiotherapy affect the type of surgical techniques, hence calling for the need of much attention. Furthermore, many problems such as accurate staging before surgery, selection of suitable neoadjuvant chemoradiotherapy method, and sensitivity prediction to preoperative radiotherapy need to be well settled.

• Publication year

  2016

• Venue

  International Journal on Biological Sciences

• Publication date

  2016-07-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.7150/ijbs.15438PMID 27489505PMCID 4971740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.

  2015cited by this paper
• Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.

  2015cited by this paper
• Dosimetric Comparison of Volumetric Modulated Arc Therapy (VMAT), 5F Intensity Modulated Radiotherapy (IMRT) and 3D Conformal Radiotherapy (3DCRT) in Rectal Carcinoma Receiving Neoadjuvant Chemoradiotherapy

  2015cited by this paper
• Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy.

  2014cited by this paper
• Transanal endoscopic surgery in rectal cancer.

  2014cited by this paper
• Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

  2014cited by this paper
• Systemic therapy of hepatocellular carcinoma: current status and future perspectives.

  2014cited by this paper
• Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options.

  2014cited by this paper
• Controversies in the pathological assessment of colorectal cancer.

  2014cited by this paper
• Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.

  2014cited by this paper
• Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study.

  2013cited by this paper
• Metformin use and improved response to therapy in rectal cancer

  2013cited by this paper
• Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.

  2013cited by this paper
• Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

  2013cited by this paper
• Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04

  2013cited by this paper
• Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications.

  2012cited by this paper
• Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

  2012cited by this paper
• Dosimetric comparison of volumetric modulated Arc therapy, step-and-shoot, and sliding window IMRT for prostate cancer

  2012cited by this paper
• Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future

  2012cited by this paper
• Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

  2012cited by this paper
• Treatment of locally advanced rectal cancer: controversies and questions.

  2012cited by this paper
• Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

  2012cited by this paper
• Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study

  2011cited by this paper
• Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma

  2011cited by this paper
• The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04.

  2011influential reference
• Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

  2011cited by this paper
• Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

  2011cited by this paper
• Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

  2010influential reference
• Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

  2010influential reference
• Trends in colorectal cancer in the south of the Netherlands 1975–2007: Rectal cancer survival levels with colon cancer survival

  2010cited by this paper
• Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.

  2010cited by this paper
• Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications

  2010cited by this paper
• Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

  2010cited by this paper
• Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

  2009cited by this paper
• Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.

  2009cited by this paper
• Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

  2009cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.

  2008cited by this paper
• Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study

  2008cited by this paper
• Optimal Surgery Time After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancers

  2008cited by this paper
• Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.

  2008cited by this paper
• Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.

  2007cited by this paper
• Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group

  2007cited by this paper
• Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.

  2007cited by this paper
• Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer

  2007cited by this paper
• A Phase II Study of Preoperative Capecitabine and Radiation Therapy in Patients With Rectal Cancer

  2007cited by this paper
• Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

  2007influential reference
• Adjuvant Treatment of Colorectal Cancer

  2007cited by this paper
• Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).

  2006cited by this paper
• Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.

  2006cited by this paper
• Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.

  2006cited by this paper
• Chemotherapy with preoperative radiotherapy in rectal cancer.

  2006cited by this paper
• Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

  2006cited by this paper
• A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer.

  2006cited by this paper
• Sphincter‐preserving radiation therapy for rectal cancer: a simulation study using three‐dimensional computerized technology

  2006cited by this paper
• Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.

  2005cited by this paper
• Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.

  2005cited by this paper
• Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.

  2004cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004influential reference
• Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.

  2003cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003cited by this paper
• Pelvic radiation and anorectal function: introducing the concept of sphincter-preserving radiation therapy.

  2002cited by this paper
• Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

  2002cited by this paper
• Rates of Circumferential Resection Margin Involvement Vary Between Surgeons and Predict Outcomes in Rectal Cancer Surgery

  2002cited by this paper
• Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.

  2002cited by this paper
• Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.

  2002cited by this paper
• Response evaluation criteria in solid tumors (RECIST): new guidelines.

  2001cited by this paper
• Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

  1999cited by this paper
• 55 Influence of the interval between pre-operative radiotherapy (preop-XRT) and surgery on the downstaging and sphincter preservation for the rectal cancer, the lyon R90 01 randomized trial

  1999cited by this paper
• Acute effects of therapeutic irradiation for prostatic carcinoma on anorectal function

  1998cited by this paper
• [Adjuvant treatment of colorectal cancer].

  1988cited by this paper

• A pilot study of clinical evidence for phenotypic circulating tumor cell counts in stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy.

  2026cites this paper
• Comparative safety and short-term outcomes of intraoperative radiotherapy versus neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a retrospective study

  2026cites this paper
• Incidence, risk factors, recovery duration, and prognostic implications of gastroparesis following radical distal gastrectomy for gastric cancer: a large retrospective cohort study.

  2026cites this paper
• Effect of chemoradiation treatment on methylated BCAT1 and IKZF1 in rectal cancer.

  2026cites this paper
• Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Concurrent Chemoradiotherapy and Robotic-Assisted Resection.

  2026cites this paper
• Radiotherapy volume delineation based on MRI and 18F-FDG-PET/MRI in locally recurrent rectal cancer

  2025cites this paper
• Modified pull-through procedure versus coloanal anastomosis with temporary stoma for low/ultra-low rectal cancer following preoperative chemoradiotherapy: protocol for a multicentre randomised controlled trial

  2025cites this paper
• Robotic versus laparoscopic total mesorectal excision for mid–low rectal cancer after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis of oncological, perioperative, and survival-related outcomes

  2025cites this paper
• tRF-17-877S6V2 modulates radioresistance via direct targeting of ENO1 in colorectal cancer.

  2025cites this paper
• Environmental pollutants and rectal cancer: The impact of water contamination.

  2025cites this paper
• The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy

  2025cites this paper
• The effect of neoadjuvant chemoradiotherapy on perioperative outcomes in rectal cancer patients following stoma reversal—a retrospective cohort analysis

  2025influential citation
• A management of patients achieving clinical complete response after neoadjuvant therapy and perspectives: on locally advanced rectal cancer

  2025cites this paper
• Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions

  2025cites this paper
• Research progress on immunotherapy combined with neoadjuvant concurrent chemoradiotherapy in pMMR/MSS locally advanced rectal cancer

  2025cites this paper
• Radiation therapy induced intestinal barrier damage and repair process - differences in salivary metabolites and monitoring of intestinal barrier function

  2025cites this paper
• Radiation-Induced Fibrosarcoma in the Stoma: A Case Report and Literature Review

  2025cites this paper
• Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoids

  2025cites this paper
• Radiomics in rectal cancer: current status of use and advances in research

  2025cites this paper
• A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer

  2025cites this paper
• Beyond the tumor region: Peritumoral radiomics enhances prognostic accuracy in locally advanced rectal cancer

  2025cites this paper
• The impact of different neoadjuvant radiotherapy doses on survival outcomes and toxicity in patients with locally advanced rectal cancer

  2025influential citation
• Combined neoadjuvant chemotherapy and immunotherapy in a hepatitis B virus-positive patient with locally advanced rectal adenocarcinoma: a case report and literature review

  2025cites this paper
• Therapeutic Management of Locally Advanced Rectal Cancer: Existing and Prospective Approaches

  2025cites this paper
• Prognostic model for log odds of negative lymph node in locally advanced rectal cancer via interpretable machine learning

  2025cites this paper
• Assessment of histopathologic response to neoadjuvant treatment in rectal adenocarcinoma

  2025cites this paper
• Recent research progress and clinical status of immunotherapy for colorectal cancer.

  2025cites this paper
• Neoadjuvant chemotherapy followed by surgery versus upfront surgery for intrahepatic cholangiocarcinoma: a systematic review and meta-analysis

  2025cites this paper
• Effect of preoperative therapy on surgical shrinkage in rectal cancer

  2025cites this paper
• Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer.

  2025cites this paper
• Mature tertiary lymphoid structures support B cell-mediated antitumour immunity and are disrupted by neoadjuvant therapy in rectal cancer: a multicentre, retrospective study

  2025cites this paper
• Ghost Ileostomy Versus Protective Ileostomy in Rectal Cancer Followed by Low Anterior Resection: A Randomized Feasibility Trial

  2025cites this paper
• Development and evaluation of the mrTE scoring system for MRI-detected tumor deposits and extramural venous invasion in rectal cancer

  2025cites this paper
• Prognosis and influencing factors of patients with different lymph node statuses after pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer

  2025cites this paper
• Constructing and validating a novel prognostic risk score model for rectal cancer based on four immune-related genes

  2025cites this paper
• Immunomarkers could predict overall survival and disease-free survival after neoadjuvant therapy and surgery due to locally advanced rectal cancer.

  2025cites this paper
• Research Progress of Imaging Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

  2025cites this paper
• Clinical value of fluorescence laparoscopic surgery on anastomotic leakage prevention in ultra-low rectal cancer: real-world multicenter retrospective evidence with neoadjuvant chemoradiotherapy stratification

  2025cites this paper
• The prognostic impact of preoperative radiotherapy in stage I rectal cancer: a retrospective cohort study revealing no survival benefit from SEER database analysis

  2025cites this paper
• Development of orthotopic mouse models for mid-low rectal cancer

  2025cites this paper
• Is Mandard tumor regression grade scoring sufficient for locally advanced rectal cancer?

  2025cites this paper
• Therapeutic Advances in Rectal Cancer.

  2025cites this paper
• Enhancing the prediction accuracy of pathological downstaging in locally advanced rectal cancer using deep learning models with preoperative MRI and clinicopathological data

  2025cites this paper
• Intensity-modulated radiation therapy can reduce acute toxicities in long-course neoadjuvant radiation therapy combined with S-1 for locally advanced rectal cancer

  2025cites this paper
• Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study

  2025cites this paper
• The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches

  2025cites this paper
• Efficacy and safety of neoadjuvant chemoradiotherapy versus chemotherapy alone in locally advanced rectal cancer

  2025cites this paper
• Imaging and Metabolic Diagnostic Methods in the Stage Assessment of Rectal Cancer

  2024influential citation
• Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition)

  2024cites this paper
• Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs

  2024cites this paper
• Association of Collagen Changes in Distal Anastomotic Margin and Anastomotic Stenosis after Neoadjuvant Chemoradiotherapy for Rectal Cancer.

  2024cites this paper
• Feasibility and limitations of combined treatment for lateral pelvic lymph node metastases in rectal cancer

  2024cites this paper
• A nomogram for predicting the overall survival in rectal cancer patients after total neoadjuvant therapy

  2024cites this paper
• Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study

  2024cites this paper
• Diagnostic advantages of transrectal ultrasound with gastrointestinal agent instillation for rectal adenoma and early-stage rectal cancer: comparison of conventional transrectal ultrasound techniques

  2024cites this paper
• Can yStage Ⅰ/Ⅱ rectal cancer patients be treated in the same way as stage Ⅰ/Ⅱ patients?

  2024cites this paper
• Neoadjuvante Chemotherapie beim operablen Kolonkarzinom

  2024cites this paper
• Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: A systematic review and meta-analysis.

  2024cites this paper
• Economic Evaluation of ‘Watch and Wait’ Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review

  2024cites this paper
• Wavelets-Based Texture Analysis of Post Neoadjuvant Chemoradiotherapy Magnetic Resonance Imaging as a Tool for Recognition of Pathological Complete Response in Rectal Cancer, a Retrospective Study

  2024cites this paper
• Effects of mesenteric artery ligation level on patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective cohort study

  2024cites this paper
• Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence

  2024cites this paper
• Pathologic Features of Rectal Adenocarcinoma after Preoperative Neoadjuvant Chemoradiation Therapy and the Prognostic Factors for Local Recurrence: A Retrospective Study at Maharaj Nakorn Chiang Mai Hospital

  2024cites this paper
• Exploring the correlation between Tom1L1 and the efficacy of neoadjuvant chemotherapy for locally progressive mid-low rectal cancer

  2024cites this paper
• Developing Individualized Follow‐Up Strategies Based on High‐Risk Recurrence Factors and Dynamic Risk Assessment for Locally Advanced Rectal Cancer

  2024cites this paper
• Effects of humanized nursing interventions on psychological well-being and quality of life in rectal cancer patients undergoing chemotherapy.

  2024cites this paper
• The association of preoperative radiotherapy and surgery for AJCC stage I-III rectal adenocarcinoma: a population-based study

  2024cites this paper
• The impact of preoperative treatments on the immune environment of rectal cancer

  2024cites this paper
• Upper Rectal Cancer: To Irradiate or Not?

  2024cites this paper
• Physical activity at diagnosis is associated with tumor downstaging after neoadjuvant chemoradiotherapy in patients with rectal cancer.

  2024cites this paper
• Tumor regression pattern may impact the prognosis of rectal cancer patients with tumor regression grade 1 after neoadjuvant chemoradiotherapy.

  2024cites this paper
• Evaluation of Volumetric Magnetic Resonance Imaging in Determining the Indication for Total Neoadjuvant Therapy in Rectal Cancer

  2024cites this paper
• Development and validation of a radiomics model based on lymph-node regression grading after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

  2023cites this paper
• A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy

  2023cites this paper
• Evaluation of the role of inflammatory blood markers in predicting the pathological response after neoadjuvant chemoradiation in patients with locally advanced rectal cancer

  2023cites this paper
• Progress in the Pathogenesis and Treatment of Radiation Enteritis

  2023cites this paper
• Effects of magnetic resonance imaging prognostic factors on neoadjuvant therapy in T3 or N+ rectal cancer: A retrospective cohort study

  2023cites this paper
• Application and Advances of Neoadjuvant Radiotherapy in Rectal Cancer

  2023cites this paper
• Surgical Outcomes in Total Neoadjuvant Therapy for Rectal Cancer Versus Standard Long-course Chemoradiation

  2023cites this paper
• Changes in colorectal cancer treatment during the COVID-19 pandemic in Japan: Interrupted time-series analysis using the National Database of Japan

  2023cites this paper
• Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration

  2023cites this paper
• Risk-factors for locally advanced rectal cancer relapse after neoadjuvant chemoradiotherapy: A single center experience

  2023cites this paper
• The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients

  2023cites this paper
• DYRK2 promotes chemosensitivity via p53‐mediated apoptosis after DNA damage in colorectal cancer

  2023cites this paper
• Ecological niches for colorectal cancer stem cell survival and thrival

  2023cites this paper
• The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience

  2023cites this paper
• Value of Pretreatment Inflammation-nutrition Score to Predict Non-response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.

  2023cites this paper
• Curative pelvic exenteration: initial experience and clinical outcome

  2023cites this paper
• Evaluation of the Response Rate to Neoadjuvant Chemoradiotherapy in Patients with Rectal Adenocarcinoma: A Retrospective Long-term Study in Two Terciary Reference Centers

  2023cites this paper
• Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy

  2023cites this paper
• The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis

  2023cites this paper
• The Effectiveness and Safety of Rectal Modular Resection in Low Rectal Cancer: A Retrospective Study

  2023cites this paper
• Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study

  2023cites this paper
• Neoadjuvante Chemotherapie beim operablen Kolonkarzinom – ein potenzieller neuer Standard?

  2023cites this paper
• Application Value of Antimicrobial Peptides in Gastrointestinal Tumors

  2023cites this paper
• Machine learning based prediction of recurrence after curative resection for rectal cancer

  2023cites this paper
• The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study

  2023cites this paper
• Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2023 edition)

  2023cites this paper
• SPARC: a potential target for functional nanomaterials and drugs

  2023cites this paper
• Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery

  2023cites this paper